Copyright
©The Author(s) 2002.
World J Gastroenterol. Feb 15, 2002; 8(1): 26-30
Published online Feb 15, 2002. doi: 10.3748/wjg.v8.i1.26
Published online Feb 15, 2002. doi: 10.3748/wjg.v8.i1.26
Group | Rate of viable cells/% | |||||
1 | 2 | 3 | 4 | 5 | 6 | |
UT control | 100 | 100 | 100 | 100 | 100 | 100 |
VEH control | 105.5 | 102.4 | 92.1 | 95.3 | 105.7 | 97.5 |
5 mg·L-1 VES | 94.8 | 101.2 | 91.4 | 144.3 | 91.4 | 74.6 |
10 mg·L-1 VES | 91.4 | 64.6 | 20.8 | 4.2 | 0 | 0 |
20 mg·L-1 VES | 53.4 | 32.9 | 4.3 | 0 | 0 | 0 |
Group | Radioactive intensity/Bq·104cell-1) | |
24 h(% of inhibition ratio) | 48 h(% of inhibition ratio) | |
UT control | 64.1 ± 10.2(0) | 143.2 ± 13.7(0) |
VEH control | 63.8 ± 10.3(1) | 141.9 ± 14.7(0) |
5 mg·L-1 VES | 61.8 ± 10.4(4) | 137.1 ± 16.3(4) |
10 mg·L-1 VES | 57.2 ± 10.7(11) | 79.3 ± 10.0(45)b |
20 mg·L-1 VES | 41.4 ± 8.0(35)b | 2.2 ± 0.3(98)b |
- Citation: Wu K, Zhao Y, Liu BH, Li Y, Liu F, Guo J, Yu WP. RRR-α-tocopheryl succinate inhibits human gastric cancer SGC-7901 cell growth by inducing apoptosis and DNA synthesis arrest. World J Gastroenterol 2002; 8(1): 26-30
- URL: https://www.wjgnet.com/1007-9327/full/v8/i1/26.htm
- DOI: https://dx.doi.org/10.3748/wjg.v8.i1.26